+351 91 257 00 03 info@formiventos.com
  • Facebook
  • Instagram
  • Facebook
  • Instagram
Formiventos
  • Inicio
  • Formações
  • News & Trends
  • Sobre nós
  • Contacto
Select Page

Quality requirements for drug-device combinations

Draft guideline on the quality requirements for drug-device combinations (PDF/302.99 KB)

Draft: consultation open

First published: 03/06/2019
Consultation dates: 03/06/2019 to 31/08/2019
EMA/CHMP/QWP/BWP/259165/2019

Guidance is provided on dossier requirements for drug-device combinations (DDCs) in the context of a regulatory submission (marketing authorisation application and post-authorisation application). The types of DDCs within the scope of this guideline are medical devices that are integral to the medicinal product, co-packaged with the medicinal product or referenced in the medicinal product information and obtained separately.

Artigos recentes

  • Applying in parallel with an EU marketing authorisation application
  • Notified bodies’ audits performed in the context of quality management system assessment
  • FORMAÇÕES 2021 : CREDITAÇÕES PELA ORDEM DOS FARMACÊUTICOS.
  • Calendário de formações 2021
  • IMPLEMENTATION ROLLING PLAN Regulation (EU) 2017/745 and Regulation (EU) 2017/746. Update dec 2020
  • Register medical devices to place on the market
  • 14ª Edição da formação sobre as BPD: “Uma revisão abrangente da temática ,que combina a legislação com casos práticos”
  • Joint strategy sets direction for EMA and EU medicines regulatory agencies to 2025
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto
  • Facebook
  • Instagram
Site feito por: cuentaconlaura.com